Skip to main content

Table 3 Values from VAS and TTO exercises in the UK general public (n = 100)

From: A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease

Health states

VAS value(N = 100)

TTO value(N = 100)

Controlled disease

 Mean (SD)

71.4 (17.9)

0.89 (0.11)

 Min - Max

10.0–98.0

0.45–1.00

Intravenous treatment

 Mean (SD)

50.0 (17.8)

0.73 (0.20)

 Min - Max

0.0–90.0

0.05–1.00

Oral treatment

 Mean (SD)

71.0 (17.1)

0.85 (0.15)

 Min - Max

10.0–96.0

0.25–1.00

Oral treatment, Alternative 1

 Mean (SD)

66.53 (17.49)

0.82 (0.23)

 Min - Max

20.0–97.0

−0.85-1.00

Oral treatment, Alternative 2

 Mean (SD)

59.1 (19.4)

0.78 (0.18)

 Min - Max

10.0–94.0

0.15–1.00

  1. SD, Standard deviation
  2. Oral treatment, alternative 1: reduced frequency of intake and side effects
  3. Oral treatment, alternative 2: higher frequency of intake and more frequent occurrence of side effects